Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

4D Molecular Therapeutics (FDMT)

  • SEC News
  • May 15, 2025, 20:29 UTC

New Form SCHEDULE 13G/A - 4D Molecular Therapeutics, Inc. Filed: 2025-05-15 AccNo: 0000921895-25-001547 Size: 25 KB

Full text
Register to leave comments
There are no comments here yet...

Search

News categories

  • Technical Exchange News(10564)
  • Event(1910)
  • SEC News(183281)
  • FDA Approval(9799)
  • Company Report(721)
  • Business News(121540)
© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin